These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1359805)

  • 21. Sedative but not analgesic alpha2 agonist tolerance is blocked by NMDA receptor and nitric oxide synthase inhibitors.
    Davies MF; Reid K; Guo TZ; Agashe GS; Amin YK; Maze M
    Anesthesiology; 2001 Jul; 95(1):184-91. PubMed ID: 11465557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of sedative and hypnotic drug combinations on transcranial magnetic motor evoked potential, bispectral index and ARX-derived auditory evoked potential index in dogs.
    Van Soens I; Struys MM; Polis IE; Tshamala M; Nollet H; Bhatti SF; Van Ham LM
    Vet J; 2009 Aug; 181(2):163-70. PubMed ID: 18682332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of alpha2-agonists in neurosurgery.
    Cormack JR; Orme RM; Costello TG
    J Clin Neurosci; 2005 May; 12(4):375-8. PubMed ID: 15925765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of pertussis toxin-sensitive G-proteins in the analgesic and anesthetic actions of alpha 2-adrenergic agonists in the rat.
    Hayashi Y; Rabin BC; Guo TZ; Maze M
    Anesthesiology; 1995 Oct; 83(4):816-22. PubMed ID: 7574062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Making sense out of antisense for the study of drug receptors.
    Michel MC; Insel PA
    J Clin Invest; 1996 Sep; 98(5):1074-5. PubMed ID: 8787666
    [No Abstract]   [Full Text] [Related]  

  • 26. [Changes in auditory brainstem responses in rats, following experimental manipulation of noradrenergic activities].
    Masui H
    Nihon Jibiinkoka Gakkai Kaiho; 1987 Sep; 90(9):1363-73. PubMed ID: 2894422
    [No Abstract]   [Full Text] [Related]  

  • 27. Awareness in cardiothoracic anaesthetic practice - where now after NAP5?
    Smith D; Goddard NG
    Anaesthesia; 2015 Feb; 70(2):130-4. PubMed ID: 25421650
    [No Abstract]   [Full Text] [Related]  

  • 28. Hypotensive and sedative properties of alpha-adrenoceptor agonists: relation to pre- and post-synaptic stimulation [proceedings].
    Birch P; Clough DP; Hatton R; Wheatley DJ
    Br J Pharmacol; 1980 Jan; 68(1):107P-108P. PubMed ID: 6101970
    [No Abstract]   [Full Text] [Related]  

  • 29. Dexmedetomidine: more than a sedative and analgesic.
    Sheen MJ; Ho ST
    Acta Anaesthesiol Taiwan; 2008 Dec; 46(4):149-50. PubMed ID: 19097960
    [No Abstract]   [Full Text] [Related]  

  • 30. The nitric oxide-cGMP system of the locus coeruleus and the hypnotic action of alpha-2 adrenergic agonists.
    Vulliemoz Y; Whittington RA; Virag L
    Brain Res; 1999 Dec; 849(1-2):169-74. PubMed ID: 10592299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of alpha-2 agonists in the equine practice: comparison between three molecules.
    Nannarone S; Gialletti R; Veschini I; Bufalari A; Moriconi F
    Vet Res Commun; 2007 Aug; 31 Suppl 1():309-12. PubMed ID: 17682902
    [No Abstract]   [Full Text] [Related]  

  • 32. [Sedation phenomena induced by alpha sympathomimetic substances].
    Delbarre B; Schmitt H
    J Physiol (Paris); 1970; 62 Suppl 2(2):267. PubMed ID: 4394932
    [No Abstract]   [Full Text] [Related]  

  • 33. Cortical evoked response audiometry thresholds and neuroleptic, sedative, hypnotic drugs.
    Dejonckere PH; Lebacq J; Coryn C
    Int Tinnitus J; 2000; 6(1):25-8. PubMed ID: 14689614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dexmedetomidine produces a hypnotic-anesthetic action in rats via activation of central alpha-2 adrenoceptors.
    Doze VA; Chen BX; Maze M
    Anesthesiology; 1989 Jul; 71(1):75-9. PubMed ID: 2568769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiological role of alpha 2-adrenoceptors in the regulation of vigilance and pain: effect of medetomidine.
    Stenberg D
    Acta Vet Scand Suppl; 1989; 85():21-8. PubMed ID: 2571274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of midlatency auditory-evoked potentials as indicator of unconsciousness in the dog: characterisation of the effects of acepromazine-thiopentone, medetomidine-thiopentone and medetomidine-butorphanol-midazolam combinations.
    Pypendop B; Poncelet L; Verstegen J
    Res Vet Sci; 1999 Aug; 67(1):35-9. PubMed ID: 10425238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dexmedetomidine premedication attenuates ketamine-induced cardiostimulatory effects and postanesthetic delirium.
    Levänen J; Mäkelä ML; Scheinin H
    Anesthesiology; 1995 May; 82(5):1117-25. PubMed ID: 7741286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dexmedetomidine--does it have a role in the perioperative setting?
    Golembiewski J
    J Perianesth Nurs; 2005 Aug; 20(4):289-91. PubMed ID: 16102711
    [No Abstract]   [Full Text] [Related]  

  • 39. Pertussis toxin and 4-aminopyridine differentially affect the hypnotic-anesthetic action of dexmedetomidine and pentobarbital.
    Doze VA; Chen BX; Tinklenberg JA; Segal IS; Maze M
    Anesthesiology; 1990 Aug; 73(2):304-7. PubMed ID: 1974396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treating agitation with dexmedetomidine in the ICU.
    Boyer J
    Dimens Crit Care Nurs; 2009; 28(3):102-9. PubMed ID: 19387269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.